Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
World Dairy ExpoWorld Dairy Expo
Not Confirmed
Not Confirmed
30 September-03 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
World Dairy ExpoWorld Dairy Expo
Industry Trade Show
Not Confirmed
30 September-03 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-secures-additional-key-us-patent-claims-for-bravyl-oral-fasudil-in-treating-als-including-reducing-neurofilament-light-nfl-302347407.html
09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-reveals-breakthrough-findings-showing-spread-of-toxic-tdp-43-pathology-greatly-reduced-in-bravyl-oral-fasudil-treated-als-patients-302324081.html
12 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-completes-patient-recruitment-for-high-dose-cohort-of-als-study-302299710.html
21 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-announces-several-patents-granted-by-uspto-strengthening-the-companys-intellectual-property-position-in-als-302280979.html
08 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-announces-treatment-of-first-patient-with-higher-dose-bravyl-in-the-real-amyotrophic-lateral-sclerosis-als-study-nct05218668-302190827.html
25 Nov 2019
// BUSINESS WIRE
ABOUT THIS PAGE